Advertisement
Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated (VRTX) Stock Overview

Explore Vertex Pharmaceuticals Incorporated’s financial performance, market position, analyst ratings, and future outlook.

VRTX●NASDAQ
HealthcareBiotechnology
$441.74
$13.40(3.13%)
U.S. Market opens in 16h 8m
Advertisement

Vertex Pharmaceuticals Incorporated (VRTX)

Meyka AI Score

Z

Key Financials

Market Cap112.1B
P/E Ratio25.06
EPS (TTM)$16.83
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$477.15
3 Months$394.52
1 Year Target$540.09

VRTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Vertex Pharmaceuticals Incorporated (VRTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $540.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.06 and a market capitalization of 112.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.13%
5-Day Change
-1.40%
1-Month Change
2.77%
3-Month Change
-7.56%
6-Month Change
-3.41%
Year-to-Date (YTD) Change
-2.56%
1-Year Change
-0.92%
3-Year Change
32.09%
5-Year Change
110.43%
All-Time (Max) Change
9716.67%

Contact Information

https://www.vrtx.com
617 341 6100
50 Northern Avenue, Boston, MA, 02210

Company Facts

6,100 Employees
IPO DateJul 24, 1991
CountryUS
Actively Trading

Frequently Asked Questions